News
Join the global community of corporate and public-sector finance industry leaders reading Global Finance monthly in print.
Click Here
News
Colombia’s First Left-Wing Prime Minister Elected
Former guerrilla rebel Gustavo Petro pledgedambitious reforms in pensions, taxes, labor and health care on the campaign trail.
Capital Raising & Corporate Finance
Dollar Rises To Euro’s Height
Russia's war in Ukraine has led to a spike in energy prices that Europe can ill afford.
News
El Salvador: Doubling Down On Bitcoin
Investors may be fleeing Bitcoin but El Salvador's president seems determined to buy the dip.
Capital Raising & Corporate Finance
Investors Flock To Gulf IPOs
Saudi Arabia and the United Arab Emirates are leading frenzied activity in Gulf equity capital markets.
News
Japan: Prime Minister Looks To Steady Ship After Abe Shock
Japan’s Prime Minister Fumio Kishida seeks to follow the path carved out by the late Shinzo Abe on foreign and defense policywhile putting his own stamp on economic policy.
News
Russia Defaults On Debt
Moscow argues that default is a technicality and that debtpayments have been held up by Western sanctions.
Executive Interviews
Sustainability Endures: Q&A With Former SVP Of Sustainability Research And Policy At Calvert Investments Bennett Freeman
Bennett Freeman, associate fellow of Chatham House and former SVP of Sustainability Research and Policy at Calvert Investments, speaks to Global Finance about environmental, social, and governance efforts worldwide.
News
UK: Boris Johnson Steps Down
Conservative Prime Minister Boris Johnson steps down just three years after winning a historic mandate.
News
Unbowed By Sanctions, Russia Claims No-Fault Default
Western sanctionshave failed to harm Russia's economy enough to stop the war, and the country's good-faith efforts to repay international investors may win sympathy for a new global financial order.
News
Global Brands, Like Kellogg, Going Sweet On Spinoffs
With M&A activity tapering off, corporate breakups like Kellogg's are popular again, with Pfizer, Johnson & Johnson and General Electric in the mix—and it's not just the US.